














































































































































































































































































































































































































































































































































































































































































































































































Characteristic Healthy	Control	(HC) Ulcerative	Colitis	(UC) Crohn’s	disease	(CD)
n 27 14 10
Male/Female 11/16 7/7 3/7
































































Characteristic Healthy	Control	(HC) Ulcerative	Colitis	(UC) Crohn’s	disease	(CD)
n 17 11 7
Male/Female 7/10 4/7 2/5










































































Antigen Clone Isotype Fluorochrome Supplier
CD3 UCHT1 IgG1,k PE	Cy5 BD	bioscience
CD14 61D3 IgG1,k PE	Cy5 BioRad-Serotec
CD14 M5E2 IgG2a,k PerCP	Cy5.5 BD	bioscience
CD14 MФP9 IgG2b,k PECF594 BD	Horizon
CD16 3G8 IgG1,k PE	Cy5 BD	bioscience
CD19 HIB19 IgG1,k PE	Cy5 BD	bioscience
CD34 581 IgG1,k PE	Cy5 BD	bioscience
CD64 10.1 IgG1,k PerCP	Cy5.5 BD	bioscience
CD64 10.1 IgG1,k PE	Cy5 Abcam
CD123 6H6 IgG1,k PE	Cy7 eBioscience
HLA-DR G46-6 IgG2a APC BD	bioscience
HLA-DR L234 IgG2a BV421 Biolegend
HLA-DR L234 IgG2a BV570 Biolegend
CD11c B-Ly6 IgG1,k BV605 BD	bioscience
CD40 LOB7/6 IgG2a FITC AbD	Serotec	(Bio-Rad)
CD40 5C3 IgG1 BV711 BD	bioscience
CD45 H130 IgG1,k BUV395 BD	horizon
CD80 L307.4 IgG1,k FITC BD	bioscience
CD80 L307.4 IgG1,k PE BD	bioscience
CD86 BU63 IgG1 FITC AbD	Serotec	(Bio-Rad)
CD86 2331(FUN-1) IgG1,k AlexaFluor700 BD	Pharmingen
CD103	(Integrin	αE) Ber-Act8 IgG1,k BV421 Biolegend,	BD	bioscience
IL-6 MQ2-13A5 IgG1,k	Rat FITC Biolegend
IL-6 MQ2-13A5 IgG1,k	Rat PE eBioscience
IL-10 JES-19F1 IgG1,k	Rat PE Biolegend
IL-10 JES-19F1 IgG1,k	Rat APC BD	bioscience/Biolegend
Integrin	β7 FIB504 IgG2a,	Rat PE Biolegend
Integrin	β7 FIB504 IgG2a,	Rat FITC Biolegend
Integrin	β7 FIB504 IgG2a,	Rat APC BD	bioscience
SIRPα	(CD172a/b) SE5A5 IgG1,k PECy7 Biolegend
Table	4.	List	of	all	antibodies	used	to	identify	and	characterise	human	DC	in	circulation	and	in	colon
for	Figs	1-5	and	Supplementary	Figs	1-2.	
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Figure	1
Bt	OMVs	stimulate	production	of	immunoregulatory	IL-10	from	whole	colonic	biopsies	and
colonic	LP	DC.	During	normal	anaerobic	growth,	Bt	cells	produce	and	release	OMVs	into	the
external	milieu.	a)	Electron	microscope	photograph	of	OMVs	collected	by	sterile	filtration	of
Bt	culture	supernatants	through	0.22	µm	membranes.	Red	arrows	point	to	spherical
nanostructures	consisting	of	lipid	bilayer.	Scale	bar,	~100	nm.	Colonic	biopsies	taken	from
the	rectosigmoid	junction	of	healthy	individuals	were	grown	in	a	pIVOC	system	mucosal	side
up	within	Snapwell	inserts	for	6	h	in	IVOC	medium	with	or	without	108-109	Bt	OMVs.	b)
Following	culture,	biopsies	were	snap-frozen	and	cytokines	and	chemokines	were	measured
within	tissue	homogenates	by	LEGENDplex	cytokine	bead	array.	Amounts	of	MCP-1,	IFN-γ,
IL-8,	IL-1β,	IL-6	and	IL-10shown	are	mean SEM	values	from	n	=	4	healthy	controls	with	two
experimental	replicates	each.	Statistical	significance	was	determined	using	nonparametric
Mann	Whitney	U	tests;	*	p<0.05;	**	p<0.01;	***	p<0.001.	Five	biopsies	each	from	proximal
and	distal	colon	of	healthy	individuals	were	washed	with	DTT/EDTA	and	digested	with
collagenase/liberase	to	obtain	total	LP	cells.	Cells	were	then	cultured	for	20	h	in	the
presence	of	either	killed	107	Bt/mL	or	1010	Bt	OMV/mL	in	complete	RPMI	medium	and	mDC
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were	examined	by	flow	cytometry.	c)	Identification	of	mDC	within	the	total	LP	cells.	d)	Mean
fluorescence	intensity	of	HLA-DR	on	total	mDC	in	response	to	medium	only,	Bt	or	Bt	OMVs.
Statistical	significance	was	determined	by	one-way	ANOVA	with	Dunnett’s	multiple
comparisons	test;	*	p<0.05.	e)	Proportion	of	mDC	expressing	IL-6	(top	panel)	and	IL-10
(bottom	panel)	within	the	colonic	LP.	Pooled	data	from	n=6	HC.	Statistical	significance	was
determined	using	non-parametric	Kruskal-Wallis	ANOVA	with	Dunn’s	multiple	comparisons
test;	*	p<0.05.
Figure	2
Bt	OMVs	stimulate	production	of	immunoregulatory	IL-10	from	whole	colonic	biopsies	and
colonic	LP	DC.	During	normal	anaerobic	growth,	Bt	cells	produce	and	release	OMVs	into	the
external	milieu.	a)	Electron	microscope	photograph	of	OMVs	collected	by	sterile	filtration	of
Bt	culture	supernatants	through	0.22	µm	membranes.	Red	arrows	point	to	spherical
nanostructures	consisting	of	lipid	bilayer.	Scale	bar,	~100	nm.	Colonic	biopsies	taken	from
the	rectosigmoid	junction	of	healthy	individuals	were	grown	in	a	pIVOC	system	mucosal	side
up	within	Snapwell	inserts	for	6	h	in	IVOC	medium	with	or	without	108-109	Bt	OMVs.	b)
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Following	culture,	biopsies	were	snap-frozen	and	cytokines	and	chemokines	were	measured
within	tissue	homogenates	by	LEGENDplex	cytokine	bead	array.	Amounts	of	MCP-1,	IFN-γ,
IL-8,	IL-1β,	IL-6	and	IL-10shown	are	mean SEM	values	from	n	=	4	healthy	controls	with	two
experimental	replicates	each.	Statistical	significance	was	determined	using	nonparametric
Mann	Whitney	U	tests;	*	p<0.05;	**	p<0.01;	***	p<0.001.	Five	biopsies	each	from	proximal
and	distal	colon	of	healthy	individuals	were	washed	with	DTT/EDTA	and	digested	with
collagenase/liberase	to	obtain	total	LP	cells.	Cells	were	then	cultured	for	20	h	in	the
presence	of	either	killed	107	Bt/mL	or	1010	Bt	OMV/mL	in	complete	RPMI	medium	and	mDC
were	examined	by	flow	cytometry.	c)	Identification	of	mDC	within	the	total	LP	cells.	d)	Mean
fluorescence	intensity	of	HLA-DR	on	total	mDC	in	response	to	medium	only,	Bt	or	Bt	OMVs.
Statistical	significance	was	determined	by	one-way	ANOVA	with	Dunnett’s	multiple
comparisons	test;	*	p<0.05.	e)	Proportion	of	mDC	expressing	IL-6	(top	panel)	and	IL-10
(bottom	panel)	within	the	colonic	LP.	Pooled	data	from	n=6	HC.	Statistical	significance	was
determined	using	non-parametric	Kruskal-Wallis	ANOVA	with	Dunn’s	multiple	comparisons
test;	*	p<0.05.
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Figure	3
Lack	of	IL-10	response	from	colonic	DC	to	Bt	OMVs	in	ulcerative	colitis.	Following	20	h
culture	of	LP	cells	from	five	proximal	and	five	distal	colon	biopsies	from	UC	patients	with	Bt
OMVs	1010/mL	or	medium	only,	DC	cytokine	responses	were	examined	by	FACS.	a)	Pooled
data	(n=3)	showing	proportions	of	mDC	expressing	IL-6	(top	left)	and	IL-10	(top	right)	and
representative	FACS	plots	from	one	UC	patient	(bottom).	b)	Comparison	of	proportions	of
mDC	expressing	IL-6	(top)	and	IL-10	(bottom)	in	UC	(n=3)	to	HC	(n=6).	Statistical
significance	was	determined	using	unpaired	t	tests;	*p<0.05.
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Figure	4
Loss	of	immunoregulatory	IL-10	response	by	circulating	DC	to	Bt	OMVs	in	CD	and	UC.	Whole
PBMC	were	separated	from	blood	of	individuals	with	inactive	Crohn’s	Disease	(CD)	or
inactive	or	active	ulcerative	colitis	(UC)	and	intracellular	cytokine	analysis	of	mDC	was
examined	by	FACS.	a)	Pooled	data	from	inactive	UC	(n=5)	and	CD	(n=	5)	patients	show
proportions	of	mDC	expressing	(a)	IL-6	in	response	to	Bt	and	Bt	OMVs	and	compared	to	HC.
b)	Pooled	data	from	inactive	UC	(n=5)	show	proportions	of	mDC	expressing	IL-10	in
response	to	Bt	and	Bt	OMVs	and	compared	to	HC.	c)	Pooled	data	from	inactive	CD	(n=5)
show	proportions	of	mDC	expressing	IL-10	in	response	to	Bt	and	Bt	OMVs	and	compared	to
HC.	Statistical	significance	was	determined	by	Brown-Forsythe	and	Welch	ANOVA	for
unequal	variance	with	Dunnett’s	T3	multiple	comparisons	test	or	two-way	ANOVA	with	Holm
Sidak’s	multiple	comparisons	test;	*p<0.05,	**	p<0.01,	***	p<0.001.	d)	Pooled	data	from
active	UC	(n=3)	showing	proportions	of	mDC	expressing	IL-6	(top)	or	IL-10	(bottom)	and
comparison	to	HC.	Statistical	significance	was	determined	by	non-parametric	Kruskal-Wallis
ANOVA	with	Dunn’s	multiple	comparison	test;	*p<0.05.
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Figure	5
Normal	IL-10	response	to	other	commensal	bacterial	species	or	OMVs	in	inactive	UC.	Whole
PBMC	from	healthy	individuals	(n=4)	or	individuals	with	inactive	UC	(n=3)	were	cultured	for
20	h	in	the	presence	of	19	species	of	killed	commensal	bacteria.	a)	Pooled	data	showing
proportions	of	mDC	expressing	IL-10	are	shown	as	mean	(+/-	SEM).	PBMC	from	healthy
individuals	(HC,	n=4-5)	or	inactive	UC	patients	(n=3)	were	cultured	for	20	h	in	the	presence
of	Pn	and	Pn	OMVs	at	varying	concentrations.	b)	The	proportion	of	mDC	expressing	IL-6	or
IL-10	from	HC	is	shown.	c)	Proportions	of	mDC	expressing	IL-6	(top)	and	IL-10	(bottom)	from
inactive	UC	and	compared	to	HC	are	shown.	Statistical	significance	was	determined	by
ordinary	one-way	ANOVA	with	Dunnett’s	multiple	comparisons	test	or	two-way	ANOVA	with
Holm	Sidak’s	multiple	comparisons	test;	****	p<0.0001.
Supplementary	Files
This	is	a	list	of	supplementary	files	associated	with	this	preprint.	Click	to	download.
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